Clinical focus and interest:
Professor Ghia’s research interest is the study of the molecular and cellular mechanisms acting in the natural history of chronic lymphocytic leukemia (CLL), including monoclonal B-cell lymphocytosis (MBL). On these topics he has published over 300 manuscripts in peer-reviewed journals.
Professor Ghia received his MD from the University of Torino, Italy, and received his PhD working at the Basel Institute for Immunology, Switzerland, studying B lymphocyte development. Next, he studied the molecular mechanisms of the pathogenesis of chronic lymphoproliferative disorders, particularly of follicular lymphoma, at the Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.
Professor Ghia is President of the European Research Initiative on CLL (ERIC) and a member of the International Workshop on CLL (iwCLL). He coauthors the EHA-ESMO guidelines for CLL treatment and the ERIC recommendations on IGHV, TP53 and MRD analyses. He is currently Associate Editor for CLL at Hemasphere, the official fournal of the EHA.